Skip to main content

Comparison of Transcatheter Aortic Valve Implantation to Medical Therapy in Prohibitive-Risk Patients

  • Chapter
Transcatheter Aortic Valve Implantation

Abstract

Aortic stenosis is the most common primary valve disease needing surgical treatment in Europe and North America. The prevalence of this disease increases over years due to the ageing population. Age and comorbidities often represent an obstacle to surgical aortic valve replacement (AVR) for those patients considered at high and prohibitive risk. In this scenario, transcatheter aortic valve replacement (TAVR) has become an appealing therapeutic option for prohibitive-risk patients with severe symptomatic aortic stenosis who were previously only medically managed and considered unsuitable for AVR. However, the delicate balance between feasibility and appropriateness needs to be accurately defined.

This chapter analyzes, basing on available literature, the outcome of such a challenging prohibitive population whether medically managed or undergoing TAVR. Recent findings from both controlled trials and registries suggest that more stringent guidelines for the older and frail population are emerging as a burning issue for health systems and caregivers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Osnabrugge RL, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12.

    Article  PubMed  Google Scholar 

  2. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Johan P, Iung HB, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos P, Alec M, Thomas V, Wendler WO, Windecker S, Zamorano JL, ESC Scientific Document Group. Valvular heart disease (management of) ESC Clinical Practice Guidelines. Eur Heart J. 2017;38(36):2739–91.

    Article  PubMed  Google Scholar 

  3. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Ann Thorac Surg. 2012;93:1340–95.

    Article  PubMed  Google Scholar 

  4. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.

    Article  PubMed  Google Scholar 

  5. Nicolini F, Agostinelli A, Vezzani A, et al. The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes. Biomed Res Int. 2014;2014:736298.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Florath I, Albert A, Boening A, Ennker IC, Ennker J. Aortic valve replacement in octogenarians: identification of high-risk patients. Eur J Cardiothorac Surg. 2010;37:1304–10.

    Article  PubMed  Google Scholar 

  7. ElBardissi AW, et al. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg. 2011;141(2):328–35.

    Article  PubMed  Google Scholar 

  8. Freeman PM, Protty MB, Aldalati O, et al. Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)—a real world retrospective cohort analysis of outcomes and cost-effectiveness using national data. Open Heart. 2016;3:e000414.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  10. Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;371(10):967–8.

    Article  PubMed  Google Scholar 

  11. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200.

    Article  PubMed  Google Scholar 

  12. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Deweytm TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, Partner Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.

    Article  CAS  PubMed  Google Scholar 

  13. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, Partner Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  14. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB, PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.

    Article  CAS  PubMed  Google Scholar 

  15. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253–69.

    Article  PubMed  Google Scholar 

  16. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145:6–23.

    Article  PubMed  Google Scholar 

  17. Tarantini G, Gasparetto V, Napodano M, Frigo AC, Fraccaro C, et al. Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification. Int J Cardiol. 2013;168:5001–3.

    Article  PubMed  Google Scholar 

  18. Haussig S, Schuler G, Linke A. Worldwide TAVI registries: what have we learned? Clin Res Cardiol. 2014;103(8):603–12.

    Article  PubMed  Google Scholar 

  19. Wendler O, Walther T, Schroefel H, et al. The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation? Eur J Cardiothorac Surg. 2011;39:853–9.

    Article  PubMed  Google Scholar 

  20. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.

    Article  CAS  PubMed  Google Scholar 

  21. Suradi HS, Hijazi ZM. TAVR update: contemporary data from UK TAVI and US TVT registries. Glob Cardiol Sci Pract. 2015;2015:21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gilard M, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Tchetche D, Carrié D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Santos PD, Meneveau N, Ghostine S, Manigold T, Guyon P, Grisoli D, Le Breton H, Delpine S, Didier R, Favereau X, Souteyrand G, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel J-P, Bourlon F, Bertrand B, Laskar M, Iung B, for the FRANCE 2 Investigators. Late outcomes of transcatheter aortic valve replacement in high-risk patients. The FRANCE-2 Registry. J Am Coll Cardiol. 2016;68(15):1637–47.

    Article  PubMed  Google Scholar 

  23. Barbash IM, Finkelstein A, Barsheshet A, Segev A, Steinvil A, Assali A, Gal YB, Assa HV, Fefer P, Sagie A, Guetta V, Kornowski R. Outcomes of patients at estimated low, intermediate, and high risk undergoing transcatheter aortic valve implantation for aortic stenosis. Am J Cardiol. 2015;116:1916–22.

    Article  PubMed  Google Scholar 

  24. Rosa VEE, Lopes AS d SA, Accorsi TAD, Fernandes JRC, Spina GS, Sampaio RO, Paixão MR, Pomerantzeff PM, Lemos Neto PA, Tarasoutchi F. EuroSCORE II and STS as mortality predictors in patients undergoing TAVI. Rev Assoc Med Bras. 2016;62(1):32–7.

    Article  PubMed  Google Scholar 

  25. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307:182–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Brecker SJD, Aldea GS. Choice of therapy for symptomatic aortic stenosis. UptoDate Jan 2017.

    Google Scholar 

  27. Freeman PM, Protty MB, Aldalati O, Lacey A, King W, Anderson RA, Smith D. Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)—a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data. Open Heart. 2016;3:e000414.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gooley R, et al. Transcatheter aortic valve implantation—yesterday, today and tomorrow. Heart Lung Circ. 2015;24:1149–61.

    Article  CAS  PubMed  Google Scholar 

  29. Kapadia SR, Murat Tuzcu E, Makkar RR, Svensson LG, Agarwal S, Kodali S, Fontana GP, Webb JG, Mack M, Thourani VH, Babaliaros VC, Herrmann HC, Szeto WY, Pichard A, Williams MR, Anderson WN, Akin JJ, Craig Miller D, Smith CR, Leon MB. Response to letter regarding article, “long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy”. Circulation. 2015;132:e118–9.

    Article  PubMed  Google Scholar 

  30. Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. J Am Coll Cardiol Intv. 2012;5:461–7.

    Article  Google Scholar 

  31. Barbanti M, Capranzano P, Ohno Y, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015;101:1485.

    Article  CAS  PubMed  Google Scholar 

  32. Wiegerinck EMA, Dijk K B-v, Koch KT, Yong ZY, Vis MM, Planken RN, Eberl S, de Mol BA, Piek JJ, Tijssen JG, Baan J Jr. Towards minimally invasiveness: transcatheter aortic valve implantation under local analgesia exclusively. Int J Cardiol. 2014;176:1050–2.

    Article  CAS  PubMed  Google Scholar 

  33. Dall’Ara G, Eltchaninoff H, Moat N, Laroche C, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Snow T, Price S, Barrero EA, Estevez-Loureiro R, Iung B, Zamorano JL, Schuler G, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Mattesini A, Tavazzi L, DiMario C, Transcatheter Valve Treatment Sentinel Registry (TCVT) Investigators of the EurObservational Research Programme (EORP) of the European Society of Cardiology. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation. Int J Cardiol. 2014;177:448–54.

    Article  PubMed  Google Scholar 

  34. Vahl TP, Kodali SK, Leon MB. Transcatheter aortic valve replacement 2016: a modern-day “through the looking-glass” adventure. J Am Coll Cardiol. 2016;67(12):1472–87.

    Article  PubMed  Google Scholar 

  35. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848–57.

    Article  PubMed  Google Scholar 

  36. Dvir D, Webb JG, Bleiziffer S, For the Valve-in-Valve International Data Registry Investigators, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valve. JAMA. 2014;312:162–70.

    Article  CAS  PubMed  Google Scholar 

  37. Fries JF. Aging, cumulative disability, and the compression of morbidity. Compr Ther. 2001;27:322–9.

    Article  CAS  PubMed  Google Scholar 

  38. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  39. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld L, et al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol. 2011;58:2151–62.

    Article  PubMed  Google Scholar 

  40. Noble S, Frangos E, Samaras N, Ellenberge C, Frangos C, Cikirikcioglu M, Bendjelid K, Frei A, Myers P, Licker M, Roffi M. Transcatheter aortic valve implantation in nonagenarians: effective and safe. Eur J Intern Med. 2013;24:750–5.

    Article  PubMed  Google Scholar 

  41. Moreno R, Salazar A, Banuelos C, Hernandez R, Alfonso F, Sabate M, et al. Effectiveness of percutaneous coronary interventions in nonagenarians. Am J Cardiol. 2004;94:1058–60.

    Article  PubMed  Google Scholar 

  42. Speziale G, Nasso G, Barattoni MC, Bonifazi R, Esposito G, Coppola R, et al. Operative and middle-term results of cardiac surgery in nonagenarians: a bridge toward routine practice. Circulation. 2010;121:208–13.

    Article  PubMed  Google Scholar 

  43. Guilfoyle MR, Drain AJ, Khan A, Ferguson J, Large SR, Nashef SA. Cardiac surgery in nonagenarians: single-centre series and review. Gerontology. 2010;56:378–84.

    Article  PubMed  Google Scholar 

  44. Bridges CR, Edwards FH, Peterson ED, Coombs LP, Ferguson TB. Cardiac surgery in nonagenarians and centenarians. J Am Coll Surg. 2003;197:347–56.

    Article  PubMed  Google Scholar 

  45. Edwards M-B, Taylor KM. Outcomes in nonagenarians after heart valve replacement operation. Ann Thorac Surg. 2003;75:830–4.

    Article  PubMed  Google Scholar 

  46. Noble S, Frangos E, Frei A, Roffi M. Transcatheter aortic valve implantation in a 99-year-old woman: are we going too far? J Am Geriatr Soc. 2012;60:1774–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giulio Pompilio .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Cite this chapter

Ricciardi, G., Trabattoni, P., Roberto, M., Agrifoglio, M., Pompilio, G. (2019). Comparison of Transcatheter Aortic Valve Implantation to Medical Therapy in Prohibitive-Risk Patients. In: Giordano, A., Biondi-Zoccai, G., Frati, G. (eds) Transcatheter Aortic Valve Implantation. Springer, Cham. https://doi.org/10.1007/978-3-030-05912-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-05912-5_11

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-05911-8

  • Online ISBN: 978-3-030-05912-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics